Value-Based Care

In a session at their 21st Annual Meeting in Hollywood, FL, National Comprehensive Cancer Network (NCCN) CEO Robert W Carlson, MD, discussed how NCCN Evidence Blocks stack up against other tools currently available for determining the value of cancer treatments. 
A tool integrating costs associated with common cancer treatments with electronic medical records was beneficial to both physicians and patients, according to results of a study presented at the conference.
In a recently published article, authors argued that the current metrics used for value-based reimbursement in health care are insufficient and that only improved health outcomes can truly measure clinical value.